AMRN
Price
$18.84
Change
+$2.10 (+12.54%)
Updated
Oct 3 closing price
Capitalization
389.66M
ANAB
Price
$30.94
Change
-$0.40 (-1.28%)
Updated
Oct 3 closing price
Capitalization
865.48M
36 days until earnings call
Interact to see
Advertisement

AMRN vs ANAB

Header iconAMRN vs ANAB Comparison
Open Charts AMRN vs ANABBanner chart's image
Amarin
Price$18.84
Change+$2.10 (+12.54%)
Volume$225.58K
Capitalization389.66M
AnaptysBio
Price$30.94
Change-$0.40 (-1.28%)
Volume$353.61K
Capitalization865.48M
AMRN vs ANAB Comparison Chart in %
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRN vs. ANAB commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a Buy and ANAB is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (AMRN: $18.84 vs. ANAB: $30.94)
Brand notoriety: AMRN: Notable vs. ANAB: Not notable
AMRN represents the Pharmaceuticals: Major, while ANAB is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 331% vs. ANAB: 59%
Market capitalization -- AMRN: $389.66M vs. ANAB: $865.48M
AMRN [@Pharmaceuticals: Major] is valued at $389.66M. ANAB’s [@Biotechnology] market capitalization is $865.48M. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $752.91B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $95.9B. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileANAB’s FA Score has 0 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • ANAB’s FA Score: 0 green, 5 red.
According to our system of comparison, ANAB is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 5 TA indicator(s) are bullish while ANAB’s TA Score has 5 bullish TA indicator(s).

  • AMRN’s TA Score: 5 bullish, 5 bearish.
  • ANAB’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ANAB is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +17.75% price change this week, while ANAB (@Biotechnology) price change was +31.21% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +4.59%. For the same industry, the average monthly price growth was +2.98%, and the average quarterly price growth was +21.92%.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

ANAB is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+4.59% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANAB($865M) has a higher market cap than AMRN($390M). ANAB YTD gains are higher at: 133.686 vs. AMRN (94.227). ANAB has higher annual earnings (EBITDA): -59.63M vs. AMRN (-70.12M). AMRN has more cash in the bank: 299M vs. ANAB (266M). AMRN has less debt than ANAB: AMRN (7.34M) vs ANAB (15.1M). AMRN has higher revenues than ANAB: AMRN (219M) vs ANAB (123M).
AMRNANABAMRN / ANAB
Capitalization390M865M45%
EBITDA-70.12M-59.63M118%
Gain YTD94.227133.68670%
P/E RatioN/AN/A-
Revenue219M123M178%
Total Cash299M266M112%
Total Debt7.34M15.1M49%
FUNDAMENTALS RATINGS
AMRN vs ANAB: Fundamental Ratings
AMRN
ANAB
OUTLOOK RATING
1..100
4533
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10063
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3839
P/E GROWTH RATING
1..100
10075
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRN's Valuation (90) in the Pharmaceuticals Other industry is in the same range as ANAB (90) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ANAB’s over the last 12 months.

ANAB's Profit vs Risk Rating (63) in the Biotechnology industry is somewhat better than the same rating for AMRN (100) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew somewhat faster than AMRN’s over the last 12 months.

AMRN's SMR Rating (96) in the Pharmaceuticals Other industry is in the same range as ANAB (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ANAB’s over the last 12 months.

AMRN's Price Growth Rating (38) in the Pharmaceuticals Other industry is in the same range as ANAB (39) in the Biotechnology industry. This means that AMRN’s stock grew similarly to ANAB’s over the last 12 months.

ANAB's P/E Growth Rating (75) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that ANAB’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNANAB
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 5 days ago
78%
Declines
ODDS (%)
Bearish Trend 25 days ago
87%
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANAB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AMRBX5.000.03
+0.60%
American Growth One B
CBBZX6.870.02
+0.29%
AB Relative Value Z
TEOIX10.760.03
+0.28%
Transamerica Emerging Markets Eq I
AMONX25.13-0.08
-0.32%
AQR Large Cap Momentum Style N
BGSAX75.61-0.31
-0.41%
BlackRock Technology Opportunities Inv A

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+12.54%
KZR - AMRN
56%
Loosely correlated
+0.77%
CNTB - AMRN
55%
Loosely correlated
+7.19%
HRTX - AMRN
44%
Loosely correlated
+1.54%
MGNX - AMRN
44%
Loosely correlated
+4.09%
ALXO - AMRN
43%
Loosely correlated
+14.14%
More

ANAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with QTTB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then QTTB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANAB
1D Price
Change %
ANAB100%
-1.28%
QTTB - ANAB
39%
Loosely correlated
N/A
CLRB - ANAB
38%
Loosely correlated
-0.34%
AMRN - ANAB
38%
Loosely correlated
+12.54%
ADCT - ANAB
37%
Loosely correlated
+2.51%
ZURA - ANAB
36%
Loosely correlated
-4.15%
More